Brokerages expect that DENTSPLY SIRONA Inc. (NASDAQ:XRAY) will report earnings per share (EPS) of $0.67 for the current fiscal quarter, Zacks Investment Research reports. Eight analysts have made estimates for DENTSPLY SIRONA’s earnings, with the lowest EPS estimate coming in at $0.64 and the highest estimate coming in at $0.73. DENTSPLY SIRONA reported earnings per share of $0.66 in the same quarter last year, which would suggest a positive year-over-year growth rate of 1.5%. The business is expected to report its next quarterly earnings results on Friday, November 3rd.

According to Zacks, analysts expect that DENTSPLY SIRONA will report full year earnings of $2.68 per share for the current fiscal year, with EPS estimates ranging from $2.66 to $2.70. For the next year, analysts anticipate that the business will post earnings of $3.02 per share, with EPS estimates ranging from $2.80 to $3.27. Zacks Investment Research’s EPS averages are an average based on a survey of sell-side research firms that that provide coverage for DENTSPLY SIRONA.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its earnings results on Wednesday, August 9th. The medical instruments supplier reported $0.65 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.65. DENTSPLY SIRONA had a negative net margin of 20.57% and a positive return on equity of 7.24%. The business had revenue of $992.70 million during the quarter, compared to the consensus estimate of $1 billion. During the same quarter last year, the firm earned $0.76 earnings per share. DENTSPLY SIRONA’s quarterly revenue was down 2.9% on a year-over-year basis.

Several equities research analysts have weighed in on the stock. Jefferies Group LLC dropped their price target on shares of DENTSPLY SIRONA from $72.00 to $66.00 and set a “buy” rating for the company in a research report on Wednesday, August 23rd. BidaskClub cut shares of DENTSPLY SIRONA from a “sell” rating to a “strong sell” rating in a research report on Wednesday, August 16th. Zacks Investment Research cut shares of DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a research report on Monday, August 14th. HC Wainwright reissued a “buy” rating and set a $68.00 price target (down previously from $74.00) on shares of DENTSPLY SIRONA in a research report on Monday, August 14th. Finally, TheStreet cut shares of DENTSPLY SIRONA from a “b” rating to a “c+” rating in a research report on Wednesday, August 9th. Three analysts have rated the stock with a sell rating, three have given a hold rating and eight have issued a buy rating to the stock. DENTSPLY SIRONA has an average rating of “Hold” and an average price target of $66.08.

DENTSPLY SIRONA (XRAY) opened at 57.83 on Friday. DENTSPLY SIRONA has a 52 week low of $52.53 and a 52 week high of $65.68. The company’s market cap is $13.27 billion. The company’s 50-day moving average is $57.90 and its 200-day moving average is $61.93.

The business also recently announced a quarterly dividend, which will be paid on Friday, October 13th. Stockholders of record on Friday, September 29th will be given a $0.0875 dividend. The ex-dividend date of this dividend is Thursday, September 28th. This represents a $0.35 annualized dividend and a dividend yield of 0.61%. DENTSPLY SIRONA’s dividend payout ratio is -10.09%.

Several large investors have recently bought and sold shares of the company. Lord Abbett & CO. LLC lifted its position in shares of DENTSPLY SIRONA by 17.6% in the 2nd quarter. Lord Abbett & CO. LLC now owns 696,865 shares of the medical instruments supplier’s stock worth $45,185,000 after purchasing an additional 104,153 shares during the period. Toronto Dominion Bank lifted its position in shares of DENTSPLY SIRONA by 23.8% in the 2nd quarter. Toronto Dominion Bank now owns 81,534 shares of the medical instruments supplier’s stock worth $5,286,000 after purchasing an additional 15,680 shares during the period. Koch Industries Inc. purchased a new stake in shares of DENTSPLY SIRONA in the 2nd quarter worth about $358,000. Westwood Holdings Group Inc. purchased a new stake in shares of DENTSPLY SIRONA in the 2nd quarter worth about $17,815,000. Finally, Security National Bank of SO Dak lifted its position in shares of DENTSPLY SIRONA by 1.1% in the 2nd quarter. Security National Bank of SO Dak now owns 18,805 shares of the medical instruments supplier’s stock worth $1,219,000 after purchasing an additional 207 shares during the period. 93.97% of the stock is owned by hedge funds and other institutional investors.

TRADEMARK VIOLATION NOTICE: “Brokerages Anticipate DENTSPLY SIRONA Inc. (XRAY) Will Announce Earnings of $0.67 Per Share” was originally published by American Banking News and is the property of of American Banking News. If you are viewing this report on another site, it was stolen and republished in violation of U.S. & international copyright & trademark law. The original version of this report can be read at https://www.americanbankingnews.com/2017/09/08/brokerages-anticipate-dentsply-sirona-inc-xray-will-announce-earnings-of-0-67-per-share.html.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Get a free copy of the Zacks research report on DENTSPLY SIRONA (XRAY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related companies with MarketBeat.com's FREE daily email newsletter.